Delivery Order SPE2DB20D1100-SPE2DB25FD5D9
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,265.90 delivery order on July 18, 2025, for HUMIRA (CF) Pen 40 mg/0.4 mls, with completion scheduled for July 21, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order valued at $12,864.94 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. The contract was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,561.65 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $13,116.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will be responsible for providing the pharmaceutical product to support military treatment programs and facilities. This delivery order is part of a larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,857.24 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $4,631.11 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. This delivery order contract has an ultimate completion date of April 15, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $8,792.11 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Humira(CF) Pen 40 mg/0.4 mL pharmaceutical products. This contract has an ultimate completion date of April 9, 2024. The delivery order was issued under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
- This is a $22,165.92 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS medication. The contract has an ultimate completion date of July 30, 2024 and is not set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,618.18 firm fixed-price contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a performance period through April 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,155.25 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide HUMIRA(CF) PEN 80 MG/0.8 MLS pharmaceutical products. This order was placed under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD5D9Delivery Order
The Defense Logistics Agency awarded a $8,685.95 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory diseases. This non-set-aside, firm fixed-price contract was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine procurement action under the federal medical supply chain supporting Department of Defense healthcare operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies globally to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen has demonstrated capability to meet DLA requirements through competitive procurement processes and maintains an extensive portfolio of brand-name and generic medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 7/18/25 |